OPKO Health (OPK) News
NASDAQ: OPKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.38+0.01 (+0.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OPK news summary
We found 3 recent headlines mentioning OPKO Health (OPK): 2 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, OPK is up 0.73% at $1.38. The most recent story, "Here's Why You Should Retain WAT Stock in Your Portfolio for Now", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest OPKO Health headlines
- Here's Why You Should Retain WAT Stock in Your Portfolio for NowWaters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.NasdaqWAT, WST, OPK, GMED
- BDX Expands U.S. Manufacturing With $19B Healthcare InvestmentBD plans a $19B U.S. investment, including $3B for manufacturing, to boost domestic medical consumables capacity and supply-chain resilience.NasdaqBDX, WST, OPK, GMED
- Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqWAT, OPK